lgc 40863 has been researched along with Abnormalities, Drug-Induced in 1 studies
*Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, SC; Cho, JH; Chung, MK; Han, SS; Roh, JK; Shim, HO; Shin, HC | 1 |
1 other study(ies) available for lgc 40863 and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Pharmacokinetic analysis for assessing developmental toxicity of a new synthetic acetolactate synthase inhibitor, LGC-40863, in rats.
Topics: Abnormalities, Drug-Induced; Acetolactate Synthase; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fetus; Male; Oximes; Pregnancy; Pyrimidines; Rats; Rats, Sprague-Dawley | 1998 |